A record number of openly LGBTQ+ lawmakers won seats in the US Congress after the 2022 midterms, while fresh developments in HIV prevention and gender-affirming care feature in The Randy Report podcast. From representation in Washington to a long-acting HIV prevention injection and a home-video release for Heated Rivalry, this week’s topics span politics, health and entertainment.

LGBTQ+ representation reaches a new high

The 2022 US midterms brought a record number of openly LGBTQ+ members into Congress, marking a notable moment for representation. The Human Rights Campaign described the result as historic, reporting that at least ten openly LGBTQ+ members of the House Equality Caucus had won election.

Pew Research Center also found a record number of openly lesbian, gay or bisexual lawmakers in the 118th Congress. Its analysis highlighted firsts including Becca Balint, the first woman and openly LGBTQ+ person to represent Vermont in Congress, and Robert Garcia, the first openly gay immigrant elected to Congress.

A record is progress, not the whole story

The midterm victories formed part of wider gains for LGBTQ+ candidates at federal, state and local levels, according to the Human Rights Campaign. Having lawmakers who can draw on personal experience may bring added visibility to debates about policies affecting LGBTQ+ communities.

But representation isn't a substitute for wider equality, the organisation cautioned. Pew's figures also focus specifically on openly lesbian, gay or bisexual members, so they shouldn't be read as a complete count of every LGBTQ+ identity in Congress.

What a generic HIV prevention injection could mean

The podcast also highlights FDA approval of a generic version of lenacapavir, a long-acting medicine used for HIV prevention. The Associated Press reports that the tentative approval is aimed at supporting access in lower-income countries, rather than opening the door to generic sales in the United States.

Lenacapavir is administered twice a year, offering a prevention option for people who may find daily pills difficult to take consistently. STAT says the generic is associated with Dr Reddy's Laboratories, but approval doesn't mean it will be available straight away: manufacturing, distribution and national regulatory decisions still matter.

A study offers a closer look at gender-affirming care

Another subject in the episode is research into transgender people who began gender-affirming medical care during adolescence. The study found generally high satisfaction and low levels of regret among respondents, while also recognising that experiences differ.

Its findings are evidence about the people who took part, not a promise that every young person will have the same experience. The researchers also noted limits to the sample and follow-up, a useful reminder that headlines about sensitive health research can flatten a more nuanced picture.

Heated Rivalry heads to home video

Fans of Heated Rivalry have another way to revisit the first season: KYMA, republishing a CBS News report, says the series is coming to Blu-ray and DVD. The show, a Crave series that aired on HBO in the United States, became a hit after premiering in late 2025.

The report says the physical release was planned for autumn 2026, with Blu-ray and DVD editions as well as a separate 4K UHD Collector's Edition. It also points to rising streaming costs and uncertainty about how long programmes will remain online as reasons some viewers prefer discs. The podcast mentions a cinema screening and a giveaway, but the KYMA report covers the home-video release rather than those separate details.

From historic election results to new ways of watching a favourite series, this episode brings together stories with very different stakes.

Source Reference Map

Story idea inspired by: [1]

Sources by paragraph:

  • Paragraph 1: [2]
  • Paragraph 2: [3]
  • Paragraph 3: [2]
  • Paragraph 4: [2], [3]
  • Paragraph 5: [4], [5]
  • Paragraph 6: [4], [5]
  • Paragraph 7: [6]
  • Paragraph 8: [6]
  • Paragraph 9: [7]
  • Paragraph 10: [7]
  • Paragraph 11: Lead article only